Abstract
Paula Molina-Giraldo, Larisa Suárez-Ortega, Marta Ramon-Krauel
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2022
Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity
10.2337/dci24-0003 · 2024
A randomized, controlled trial of liraglutide for adolescents with obesity
10.1056/nejmoa1916038 · 2020
Once-weekly semaglutide in adolescents with obesity
10.1056/nejmoa2208601 · 2022
Unintended consequences of obesity pharmacotherapy: A nutritional approach to ensuring better patient outcomes
10.3390/nu17111934 · 2025
No additional external references are available.